News
7 November 2018
José Manuel Franco, COO of VIVEbiotech, participates in a Roundtable on Ideas on how to transform knowledge into economic activity
The COO of VIVEbiotech, José Manuel Franco, participated in a Roundtable of Ideas that took place at CIC bioGUNE. José María Mato, the General...
Read more2 November 2018
VIVEbiotech participates in the 26th annual congress of the ESGCT that took place in Lausanne
VIVEbiotech has participated in the 26th Congress of the European Society of Gene and Cell Therapy (ESGCT) that took place in Lausanne, Switzerland, on 16, 17, 18 and 19...
Read more10 October 2018
The Chief Scientific/Technology Officer of VIVEbiotech, Juan Carlos Ramírez, participates in a symposium on gene therapy at the UAM
Dr. Juan Carlos Ramírez, Chief Scientific/Technology Officer of VIVEbiotech, participated in the informative symposium entitled "Present and Future Vision of Gene Therapy: 360º Approach"...
Read more8 October 2018
VIVEbiotech signs three contracts for gene therapy clinical trials for 1.4 million euros
VIVEbiotech has signed three new contracts for the production of lentiviral vectors for three clinical trials for an amount of 1.4 million euros. Two of them...
Read more5 October 2018
VIVEbiotech participates in the last edition of Biospain in Seville
Biospain is a biennial biotechnology event organized by Asebio (Spanish Association of Biocompanies) in which more than 3000 individual meetings are held and more than 800 companies...
Read more24 September 2018
VIVEbiotech obtains the CIR Certification from the Ministry of Higher Education, Research and Innovation of the Government of France
VIVEbiotech S.L. has obtained the CIR certification (Crédit d'Impôt Recherche) which reinforces its position as an R & D provider for the French...
Read more13 September 2018
VIVEbiotech participates in the International Conference on Lymphocyte Engineering
VIVEbiotech will participate in the International Conference on Lymphocyte Engineering that will take place in Madrid from the 13th to the 15th of September.
Read more5 July 2018
The Economic Promotion Commission of the General Councils of Gipuzkoa visits VIVEbiotech
The Commission of Economic Promotion of the General Councils of Gipuzkoa visited the facilities of VIVEbiotech. Throughout the visit, the Commission was able to learn...
Read more29 June 2018
VIVEbiotech joins #tusonrisaporeldravet campaign organized by the Apoyo Dravet association
VIVEbiotech collaborates with the Apoyo Dravet association which is "is the evolution of the activities of a group of volunteers, which arises in the Donostia...
Read more26 June 2018
VIVEbiotech receives the “Research” award from the first edition of the San Sebastian Radio Awards for Excellence
Last Friday the ceremony of the first edition of Radio San Sebastian Awards for Excellence took place in San Sebastian Palace of Congress.
Read moreDestacadas
4 March 2024
Spanish researchers to design proteins using AI to make advanced therapies more efficient
20 February 2024
Scrip Citeline Commercial reports VIVEbiotech’s predictions for 2024
14 February 2024
VIVEbiotech forecasts significant growth in lentiviral vectors and CAR-T therapies for 2024
13 February 2024
9 February 2024